repaglinide has been researched along with Endometrioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azadbakht, M; Cheraghbaeigi, S; Kalehoei, E; Moradi, M; Parvini, M; Saghari, S; Zhaleh, H | 1 |
1 other study(ies) available for repaglinide and Endometrioma
| Article | Year |
|---|---|
In vitro maturation medium supplementation: utilization of repaglinide, L-carnitine, and mesenchymal stem cell-conditioned medium to improve developmental competence of oocytes derived from endometriosis mouse models.
Topics: Animals; Antioxidants; Blastocyst; Carbamates; Carnitine; Culture Media, Conditioned; Dietary Supplements; Endometriosis; Female; Fertilization in Vitro; Humans; In Vitro Oocyte Maturation Techniques; Mesenchymal Stem Cells; Mice; Oocytes; Piperidines; Pregnancy | 2022 |